Key Points BrainsWay and Mindful Health Solutions are collaborating to expand access to noninvasive mental health treatments. The initiative includes BrainsWay Deep TMS and its…
Evommune Inc. (NYSE: EVMN) shares surged approximately 27% in intraday trading today, rebounding sharply from Tuesday’s closing price of $5.16. The rally follows a steep…
October 27, 2026
Firefly Highlights Versus Platform in Non-Invasive Brain-Computer Interface Strategy
Key Points Firefly’s commercially available Versus platform combines a wireless EEG headset with interactive training software. The company reports more than 3,000 headsets shipped and…
October 27, 2026
PRISM Mid-Dy Movers: MedTech and EV are Today’s Leaders.
Quantum-Si Incorporated (NASDAQ: QSI) shares are surging approximately 19% by midday Tuesday, extending recent momentum in the protein sequencing technology company. Investor interest continues to…
October 20, 2026
Vivos Closes SOD Sciences Deal, Targeting Potential Access to More Than 325,000 Patients
Key Points Vivos acquired an 11% fully diluted stake in SOD Sciences and 50% co-ownership of its experimental pseudohypoxia test. The company paid with convertible…
October 16, 2026
PRISM Mid-Day Movers: MedTech and Biotech are Today’s Leaders.
CytoSorbents (NASDAQ: CTSO) rose 14.71% to $3.51 by mid-day, with no new company announcement behind the move. The gain follows recent CytoSorb data presentations at…
Key Points A randomized trial found better preservation of erectile function and bladder control with TULSA than with robotic prostate surgery at six months. Additional…
Key Points Pulse Biosciences partnered with the Clayman Thyroid Center in Tampa for commercial use and clinical research involving its nPulse Vybrance System. The center…
October 13, 2026
BrainsWay Expands Insurance Coverage for Accelerated Deep TMS to Over 70 Million U.S. Lives
Key Points BrainsWay says favorable U.S. insurance policies for its SWIFT Accelerated Deep TMS protocol now cover more than 70 million lives. The expansion creates…
Key Points Humacyte’s interim Phase 3 V012 results were accepted for a late-breaking oral presentation at ASN Kidney Week 2026. The randomized trial compares its…
October 09, 2026
PRISM Mid-Day Movers: MedTech and Fintech are Today’s Leaders.
Quantum-Si Incorporated (NASDAQ: QSI) shares surged 27.23% to approximately $1.55 today, rising from Thursday’s $1.22 close. Trading volume topped 22.2 million shares—more than five times…
Key Points NeuroOne joined a Dartmouth-led research project to advance neurotransmitter sensing technology for potential use in humans. The NIH grant provides approximately $1 million…